Jeff Yass’s ProShares UltraPro Short NASDAQ Biotechnology ZBIO Stock Holding History

Jeff Yass’s Portfolio ZBIO Stock Details ZBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-6,250	Closed	-$410K	–	10243
2015 Q3	$410K	Buy	+6,250	New	+$284K	﹤0.01%	7490

Other funds holding ZBIO

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Jeff Yass's ZBIO Position: Q1 2020 in Review

Jeff Yass sold out of ProShares UltraPro Short NASDAQ Biotechnology (ZBIO) in Q1 2020, closing a stake of 20,322 shares — an estimated $186K sold.

Jeff Yass first reported a position in ZBIO in Q1 2016 and held it in 12 quarters. The position peaked at $944K in Q1 2016. 1 fund tracked by Wall St. Rank holds ZBIO as of Q1 2020.

Jeff Yass reported no remaining ProShares UltraPro Short NASDAQ Biotechnology position as of Q1 2020 after selling out during the quarter.
Jeff Yass sold 20,322 ProShares UltraPro Short NASDAQ Biotechnology shares in Q1 2020, an estimated $186K.
Jeff Yass first reported a position in ProShares UltraPro Short NASDAQ Biotechnology in Q1 2016 and held it in 12 quarters.
Jeff Yass's ProShares UltraPro Short NASDAQ Biotechnology position peaked at $944K in Q1 2016.
1 fund tracked by Wall St. Rank held ProShares UltraPro Short NASDAQ Biotechnology as of Q1 2020.

Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.